Literature DB >> 15579275

Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease.

Pawel Ciborowski1, Yoshimi Enose, Andrea Mack, Melissa Fladseth, Howard E Gendelman.   

Abstract

Neurotoxic secretory products from virus-infected mononuclear phagocytes (MP; perivascular macrophages and microglia) orchestrate the neuropathogenesis of human immunodeficiency virus type one (HIV-1) infection. To uncover such MP products and their relationship to disease, we used a proteomics platform consisting of one dimensional polyacrylamide gel electrophoresis (1-DE), mass spectrometry peptide sequencing, and bioinformatics in order to identify from HIV-1-infected monocyte-derived macrophages (MDM) secretions. Matrix metalloproteinase 9 (MMP 9) secreted in abundance in MDM was markedly down-regulated following viral infection. A negative correlation between MMP 9 and HIV-1 reverse transcriptase activity was shown by quantitative Western blot assays. These data further demonstrate immunoregulatory activities of HIV-1-infected MDM providing unique insights into cellular function in disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579275     DOI: 10.1016/j.jneuroim.2004.08.033

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

1.  PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.

Authors:  Wen Huang; Ibolya E András; Geun Bae Rha; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2011-08-12       Impact factor: 5.191

2.  The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.

Authors:  Gang Zhang; Dongwei Guo; Prasanta K Dash; Mariluz Araínga; Jayme L Wiederin; Nicole A Haverland; Jaclyn Knibbe-Hollinger; Andrea Martinez-Skinner; Pawel Ciborowski; Val S Goodfellow; Tadeusz A Wysocki; Beata J Wysocki; Larisa Y Poluektova; Xin-Ming Liu; JoEllyn M McMillan; Santhi Gorantla; Harris A Gelbard; Howard E Gendelman
Journal:  Nanomedicine       Date:  2015-10-22       Impact factor: 5.307

3.  Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations.

Authors:  Joseph R Berger; Malcolm Avison; Yunanan Mootoor; Carol Beach
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

4.  Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment.

Authors:  Wojciech Rozek; Jayme Horning; James Anderson; Pawel Ciborowski
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

5.  The Impact of Mass Spectrometry-Based Proteomics on Fundamental Discoveries in Virology.

Authors:  Todd M Greco; Benjamin A Diner; Ileana M Cristea
Journal:  Annu Rev Virol       Date:  2014-07-14       Impact factor: 10.431

6.  Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins.

Authors:  Lijun Zhang; Xiaofang Jia; Xiaojun Zhang; Jianjun Sun; Xia Peng; Tangkai Qi; Fang Ma; Lin Yin; Yamin Yao; Chao Qiu; Hongzhou Lu
Journal:  Proteome Sci       Date:  2010-03-12       Impact factor: 2.480

7.  Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production.

Authors:  Eric Y Chan; Wei-Jun Qian; Deborah L Diamond; Tao Liu; Marina A Gritsenko; Matthew E Monroe; David G Camp; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

8.  Macrophage secretome from women with HIV-associated neurocognitive disorders.

Authors:  Krystal Colon; Juliana Perez-Laspiur; Raymond Quiles; Yolanda Rodriguez; Valerie Wojna; Scott A Shaffer; John Leszyk; Richard L Skolasky; Loyda M Melendez
Journal:  Proteomics Clin Appl       Date:  2015-11-18       Impact factor: 3.494

9.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

10.  Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.

Authors:  Shumei Bai; Shilian Liu; Xuxiao Guo; Zhaoyu Qin; Banqin Wang; Xiaohong Li; Yanjiang Qin; Yi-Hsin Liu
Journal:  Mol Vis       Date:  2009-08-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.